Focus on Breast Cancer

Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival.

If you've never had a mammogram, or if you have the kind of tissue that can create hard-to-read images on an x-ray, we now offer a diagnostic test that you should know about.

Norris Cotton Cancer Center (NCCC) has put a yellow tint on its October breast cancer awareness efforts, a month usually draped in the color pink.

Welcome Breast Cancer Awareness Month at BJs Hooksett with NCCC to celebrate survival and honor those who offer hope, support, and love in our Community of Strength.

The notion that a woman with breast cancer has to take it easy and limit her activities is being replaced by a new, more accurate image—a physically active participant in her own recovery.

One of the most satisfying aspects of Tracy Onega's work with the New Hampshire Mammography Network (NHMN), she says, is creating an opportunity for the women of New Hampshire to feel like they are contributing to a significant public-health outcome.

When a patient first walks into Martha Travis-Cook's cozy and quiet office, they're often in a state of shock.

Happy hour at Molly's Restaurant in Hanover. Most of the nine women gathered at the long, rectangular table order margaritas, only two dollars a drink. "You can't beat the price," one of them laughs. In fact, there is a lot of laughter among this group of friends, teachers, moms, writers, grandmas, businesswomen, and sisters in life experience. They have dubbed themselves TGIF—thank goodness for Fridays, and Mondays, and every day of life after cancer.

On meeting Cindy Carroll one might be tempted to describe her as petite. She's slight of build and just over five feet tall. Talk to her for any length of time, however, and that impression quickly changes.